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Objective: To investigate the long-term performance of aortic valve repair,
we analyzed the results obtained in a 22-year period in patients who
underwent repair of nonsevere rheumatic aortic valve disease during other
valvular procedures. Methods: Fifty-three patients (mean 40 6 11.6 years of
age) with predominant rheumatic mitral valve disease had concomitant
aortic valve disease in association with serious tricuspid valve disease in 25
of them. Preoperatively, aortic valve disease was considered moderate in
47.2% of the patients and mild in 52.8%. All patients underwent reparative
techniques of the aortic valve (free edge unrolling, 44; subcommissural
annuloplasty, 40; commissurotomy, 36) at the time of mitral or mitrotri-
cuspid valve surgery. The completeness of follow-up during the closing
interval was 100%, with a mean follow-up of 18.8 years (range 8 to 22.5
years). Results: Hospital mortality rate was 7.5%. Of 49 surviving patients,
26 (53.1%) died during late follow-up. The actuarial survival curve includ-
ing hospital mortality was 35.4% 6 8.7% at 22 years. For patients who
underwent mitral and aortic valve surgery, the actuarial survival curve at
22 years was 32.3% 6 13%, whereas for patients who had a triple-valve
operation the survival was 37.0% 6 10.1% (p 5 0.07). Twenty-five patients
underwent an aortic prosthetic valve replacement. Actuarial free from
aortic structural deterioration and valve-related complications at 22 years
was 25.3% 6 9.3% and 12.7% 6 4.8%, respectively. Conclusions: Long-term
functional results of reparative procedures of nonsevere aortic valve
disease in patients with predominant rheumatic mitral valve disease have
been inadequate at 22 years of follow-up. According to these data, conser-
vative operations for rheumatic aortic valve disease do not seem appropri-
ate. (J Thorac Cardiovasc Surg 1998;115:1130-5)
Reconstructive surgery for aortic valve disease isan attractive idea in the light of the excellent
long-term results of mitral and tricuspid valve re-
pair.1-3 Under a historical perspective, aortic surgery
started with conservative procedures that fell into
disuse when reliable valve prostheses became avail-
able. Aortic valve repair has recently elicited a
renewed interest as a result of encouraging data
published in the past few years.4-6 The lack of
long-term results, however, limits the same level of
general application witnessed for prosthetic valve
replacement.
To investigate the long-term performance of aor-
tic valve repair, this report retrospectively analyzes
the results obtained in a 22-year period in patients
with nonsevere aortic valve disease and predomi-
nant mitral valve disease of a rheumatic cause, who
underwent classical reparative techniques of the
aortic valve at the time of mitral valve operation.
Materials and methods
Between June 1974 and December 1988, 53 patients
with rheumatic mitral or mitrotricuspid valvulopathy in
association with nonsevere aortic valve disease underwent
concomitant two-valve or triple-valve operations. The
study population was made up of 41 women (77.3%) and
12 men (22.6%), with a mean age of 40.8 6 11.6 years
(range 17 to 69 years). Two (3.8%) patients had a previous
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repair of the mitral, aortic, or both valves with cardiopul-
monary bypass, and seven (13.2%) had a closed mitral
commissurotomy. At the time of operation, 9 (17.1%)
patients were in New York Heart Association functional
class II, 40 (75.5%) in class III, and 4 (7.5%) in class IV.
Cardiac rhythm was in atrial fibrillation in 32 (60.4%)
patients and in sinus rhythm in the remaining 21 (39.6%)
patients.
In all patients the diagnosis was based on results of
cardiac hemodynamics. Mean left ventricular ejection
fraction was 55.9% 6 9.4% (range 37% to 87%), mean
cardiac index 2.4 6 0.7 L/min/m2 (range 1.2 to 4.3
L/min/m2), mean systolic pulmonary artery pressure
42.9 6 13 mm Hg (range 22 to 84 mm Hg), and mean
pulmonary capillary pressure was 20.9 6 6.2 mm Hg
(range 8 to 35 mm Hg). The aortic valve disease consisted
of pure stenosis in 8 (15.1%) patients, with a mean aortic
valve gradient of 21.8 6 15.2 mm Hg, mixed lesion in 10
(18.9%), and pure aortic insufficiency in 35 (66.1%).
Aortic regurgitation was mild (grade I/III) in 24 (45.3%)
patients and moderate (grade II/III) in 21 (39.6%) pa-
tients. Overall, 28 (52.8%) patients had a mild aortic valve
disease, and the remaining 25 (47.2%) patients had a
moderate aortic valve disease. In all patients, however,
rheumatic mitral valve disease was the predominant le-
sion. Twenty-five (47.2%) patients had an associated
serious tricuspid valve disease.
All operations were performed with standard cardio-
pulmonary bypass. Myocardial protection was achieved
with systemic hypothermia to 25° C and local hypothermia
with cold saline until 1977 and by cardioplegic arrest
thereafter.
The aortic valve disease was initially evaluated through a
J-shaped aortotomy incision. The mitral valve was repaired
first followed by reconstruction of the aortic valve and
tricuspid valve repair. The type of technique used for mitral
and tricuspid valve repair is shown in Table I.
Mitral valve reparative procedures were done in 41
(77.3%) patients. In the 25 patients with associated tricus-
pid valve disease, reparative procedures were done in 24
(96%). Aortic valve findings are described in Table II, and
reconstructive procedures for aortic valve disease are
shown in Table III. The technique most frequently used
was free edge unrolling followed by subcommissural an-
nuloplasty and commissurotomy. An average of 2.4 recon-
structive procedures per patient was required. The mean
time of myocardial ischemia was 64.9 6 16.3 minutes
(range 43 to 140 minutes), and the mean time of cardio-
pulmonary bypass was 104.6 6 27.7 minutes (range 49 to
175 minutes). Intraoperative testing was only made by
direct observation of the repaired aortic valve.
All surviving patients were evaluated before discharge
or during the first postoperative year by means of left
cardiac catheterization, left ventriculography and aortog-
raphy in 24 patients, and echocardiography in the remain-
ing 25 patients. Surviving patients in atrial fibrillation were
treated with acenocoumarol for 3 months or permanently
in patients with a giant left atrium or massive atrial
thrombus. All other patients received antiplatelet drugs
for at least 3 months after operation. Thromboembolic
prophylaxis was modified according to the patient’s re-
quirements during follow-up.
Follow-up of all surviving patients was done at regular
intervals of 3, 6, and 12 months after operation and then
annually. Salient information was stored in a database for
outpatient clinical consultations of the Spanish Ministry of
Health. Follow-up was completed from October to De-
cember 1996. All patients had a Doppler echocardio-
graphic study during the closing interval. The complete-
ness of follow-up during the closing interval was 100%,
with a mean follow-up of 18.8 years (range 8 to 22.5
years). Cumulative duration of follow-up was 925.76 pa-
tient-years.
Actuarial curves were obtained by the life-table
method.
Results
Hospital mortality occurred in four (7.5%) pa-
tients. The cause of death was heart failure in three
patients and cerebrovascular accident in one. In the
49 surviving patients echocardiographic or hemody-
namic assessment over the first 12 months after
operation demonstrated a normal functioning aortic
valve in 10 (20.4%) patients and mild residual
lesions in 30 (61.2%) patients (regurgitation, 25;
Table I. Operative techniques in 53 patients with
rheumatic mitral and tricuspid valve disease
Operation
Mitral valve Tricuspid valve
No. % No. %
Bioprosthetic replacement 12 22.6 1 1.9
Flexible ring annuloplasty 31 58.5 19 35.8
De Vega’s annuloplasty 1 1.9
Commissurotomy 36 67.9 12 22.6
Chordal repair 2 3.8
Table II. Anatomic lesions in the aortic valve
Lesion No. %
Commissural fusion 32 60.4
Free edge thickening 27 50.9
Free edge rolling 26 49.1
Leaflet prolapse 2 3.8
Free edge calcification 1 1.9
Commissural calcification 1 1.9
Table III. Reconstructive procedures for aortic valve
disease
Procedure No. %
Free edge unrolling 44 77.4
Subcommissural annuloplasty 40 75.5
Commissurotomy 36 67.9
Supraaortic crest enhancement 9 16.9
Cusp extension with pericardial graft 2 3.8
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double lesion, 4; stenosis, 1). Moderate residual
lesions were documented in nine (18.4%) patients
(regurgitation, 5; double lesion, 4).
Of the 49 surviving patients, 26 (53.1%) died
during the late follow-up. The causes of death were
heart failure in 10 patients, reoperation in 5, pros-
thetic endocarditis in 2, noncardiac death in 3, and
unknown in 6. The actuarial survival curve, includ-
ing hospital mortality, was 35.4% 6 8.7% at 22 years
(Fig. 1). For the subgroup of 28 patients who
underwent mitral and aortic valve surgery, the actu-
arial survival curve at 22 years was 32.3% 6 13%,
whereas for the 25 patients who had triple-valve
operation it was 37.0% 6 10.1% (Fig. 2).
Of the 49 surviving patients, 31 (63.3%) required
a valve reoperation. The reoperation was necessary
because of mitral valve dysfunction or structural
deterioration of the mitral bioprosthesis in 30 pa-
tients (moderate lesions in 26.7% and severe in the
remaining 73.3%), aortic valve dysfunction in 25,
and tricuspid valve dysfunction in 10. Indications for
operation included isolated mitral valve dysfunction
in 6 patients, mitral and aortic valve dysfunction in
15, aortic and tricuspid valve dysfunction in 1, and
triple valve dysfunction in 9. Predominant aortic
stenosis was the cause of reoperation in 10 patients
and predominant aortic regurgitation in the remain-
ing 15. At the time of reoperation aortic valve
lesions were considered mild in 3 patients, moderate
in 7, and severe in 15. In the three patients with mild
aortic valve lesion, prosthetic valve replacement was
indicated to prevent a third operation because all 3
had a mitral valve replacement performed. In all
aortic valve reoperations a prosthetic valve replace-
ment was done. Hospital mortality for valve-related
reoperation was 16.1% (5 of 31 patients). Fig. 3
shows survival free from structural deterioration of
the mitral valve (21.3% 6 8.1%) and the aortic valve
(25.3% 6 9.3%).
Of the 10 patients with a normal functioning
aortic valve after repair, 6 (60%) were reoperated.
Reoperation was performed in 18 (60%) of the 30
patients with mild aortic valve lesions and in 7
(77.7%) of the 9 patients with moderate lesions.
Actuarial curves of survival free from structural
deterioration of the repaired aortic valve at 22 years
was 20.0% 6 17.9% for patients with normal func-
tioning valves, 33% 6 11.4% for those with mild
aortic lesions, and 22.2% 6 13.9% for those with
moderate residual lesions (Fig. 4). The comparison
of patients without residual lesions with patients
with mild aortic dysfunction did not reveal signifi-
cant differences. However, statistically significant
differences were found between patients without
residual lesion and those with moderate valve dys-
function (p 5 0.007), and between patients with mild
versus moderate aortic dysfunction (p 5 0.02).
Of the 25 patients reoperated because of aortic
structural deterioration, none had surgery within the
first 2 postoperative years, four patients after 3 to 5
years, eight patients after 6 to 10 years, seven
patients after 11 to 15 years, and the remaining six
beyond 15 years. Actuarial freedom from structural
deterioration of the aortic valve was 89.3% 6 4.5%
at 5 years, 71.2% 6 6.8% at 10 years, 51.8% 6 8.0%
at 15 years, and 25.3% 6 9.3% at 22 years (Fig. 3).
Twelve patients had a thromboembolic episode
during the follow-up (six central with permanent
Fig. 1. Actuarial survival curve.
Fig. 2. Actuarial survival curve for patients undergoing
mitral and aortic valve reconstructive procedures (top;
M1A) and mitral, aortic, and tricuspid valve procedures
(bottom; M1A1T) (p 5 0.07).
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neurologic impairment). The actuarial survival
curve for freedom from thromboembolic events at
22 years was 65.9% 6 8.7% (Fig. 5). Survival free
from valve-related complications at 22 years was
12.7% 6 4.8% (Fig. 5).
At the closing interval of follow-up, 9 (16.9%) of
the 53 patients were alive and had the repaired
native aortic valve. Eight of them were in New York
Heart Association functional class I or II, and one in
was in functional class III. Echocardiographic eval-
uation during the closing interval showed mild aortic
valve disease in four patients and moderate to
severe aortic valve disease in the remaining five
patients who are pending candidates for cardiac
operation.
Discussion
It is generally accepted that reconstructive oper-
ation for mitral valve disease offers better immedi-
ate and long-term results than prosthetic valve re-
placement,1 even in patients with rheumatic heart
disease.2, 3 Mitral valve reconstruction has become a
routine procedure for many operative teams with
satisfactory results. In contrast operative experience
with reconstructive surgery of the aortic valve is
limited. Although a number of authors have recently
reported acceptable short-term results,4-8 the long-
term stability of aortic valve repair in terms of the
future development of aortic regurgitation or steno-
sis is currently unpredictable.
A separate but related problem is whether aortic
valve repair should be performed in patients re-
ferred for other cardiac operations who have asso-
ciated aortic valve disease that is not severe enough
to warrant valve replacement but may progress
further in subsequent years, necessitating cardiac
reoperation.9-11 Although polyvalvular involvement
is common in patients with rheumatic heart disease,
the decreasing prevalence of the rheumatic cause
has been an impediment to know the natural history
of nonsevere aortic valve disease. On the other
hand, results of two-valve operations are worse than
isolated repair of the mitral valve. In this group of
patients with mild to moderate aortic valve lesions
operated on 8 to 22 years ago in whom mitral valve
disease was predominantly repaired, a number of
Fig. 3. Actuarial freedom from mitral or aortic structural
deterioration.
Fig. 4. Actuarial freedom from aortic structural deterio-
ration according to initial result of aortic valve repair;
normal functioning valves versus moderate dysfunction
(p 5 0.007), mild versus moderate dysfunction (p 5 0.02),
and normal functioning versus mild dysfunction (p 5 not
significant).
Fig. 5. Actuarial freedom from thromboembolism (top)
and valve-related complications (bottom).
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previously described techniques12 were used for
reconstructive operation of the aortic valve. Imme-
diate results were not as favorable as expected.
These initial discouraging results may be explained
by the method used to test aortic valve competence,
directed observation, which is obviously less reliable
than transesophageal echocardiography or visualiza-
tion of the aortic valve before unclamping the aorta
with an endoscopic instrument,13 or by inadequacy
of the techniques used for aortic repair to obtain a
normal functioning valve. Interestingly, initial re-
sults (within a year of operation) of aortic valve
operation have a predictive value over the next years
in terms of the need for subsequent surgery. A
significantly higher incidence of reoperation caused
by aortic structural deterioration was found in re-
paired aortic valves with moderate residual lesions
compared with normal functioning valves or valves
with mild dysfunction.
With a completeness of follow-up during the
closing interval of 100%, late mortality was high.
This finding indicates the poor prognosis of patients
with rheumatic heart disease and polyvalvular in-
volvement as shown by a substantially better long-
term survival in patients with two-valve operations
than in those with triple-valve operations. The anal-
ysis of the actuarial survival curve showed a contin-
uous mortality throughout the follow-up period,
with a linearized rate of 3.0% patient-years exposed
to death.
Because all patients underwent mitral valve repair
or bioprosthetic valve replacement, there was a
reasonable expected need to undergo reoperation in
the future. Of the 49 surviving patients, 31 required
a valve reoperation. In 25 of the 31 reoperated
patients the repaired aortic valve was replaced by a
prosthesis because of evidence of severe or moder-
ate residual aortic valve disease (88%, 22 of 25).
Survival free from valvular reoperation showed a
linearized rate of 3.4% patient-years exposed to
reoperation. The results obtained in relation to
thromboembolism with a linearized incidence of
1.4% patient-years are noticeably worse than those
expected in patients with rheumatic heart disease
undergoing isolated mitral valve repair.1, 3
It should be noted that in the very long follow-up
(at 22 years), 22 of the 41 patients who underwent
mitral valve repair required reoperation because of
structural deterioration of the repaired valve
(48.9%), suggesting that valve repair procedures are
not going to last forever even in the mitral position.
The idea of conservative operations for acquired
aortic valve disease is very attractive, but caution
should be exerted because ultrasonic debridement
of the aortic valve,14, 15 with promising initial hemo-
dynamic results, has recently been shown to be
associated with early recurrence of severe and pro-
gressive aortic insufficiency. In our experience the
surgical techniques used for aortic valve repair were
not changed since the beginning of the study in
1974. Results at 20 years in this group of patients are
inadequate given the high incidence of reoperations
and valve-related complications. On the other hand,
a lower incidence of structural deterioration of the
aortic valve compared with replacement with the
Hancock I porcine bioprosthesis was not achieved.16
Operative management of nonsevere aortic valve
lesions in young patients with a predominant mitral
valve disease should be individualized, and, in our
opinion, if an adequate mitral valve repair is
achieved, an attitude toward ignoring the aortic
lesion may be adopted, which, in turn, would initially
decrease the risk of time-related valve complica-
tions.
Other authors, however, have recently introduced
new aortic valve reparative procedures6, 8, 17-20 to
repair nonrheumatic aortic valve lesions, including
cusp extension with bovine pericardium,18 triangular
resection of the free edge of the prolapsing leaflet,6
and aortic valve reimplantation inside a collagen-
impregnated tubular Dacron graft for patients with
aortic incompetence and aneurysm of the ascending
aorta,17 with encouraging short-term results, partic-
ularly in cases of predominant valve insufficien-
cy.6, 19
In conclusion, early and long-term functional
results of reparative procedures of nonsevere aortic
valve disease in patients with predominant rheu-
matic mitral valve disease have been inadequate at
22 years of follow-up. According to these data,
conservative operations for rheumatic aortic valve
disease do not seem appropriate.
We are indebted to Marta Pulido, MD, for editing the
manuscript and editorial assistance.
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